Ready for rescue – new nasally administered glucagon for severe hypoglycaemia available in Canada

23 January 2020 - Eli Lilly Canada introduces Baqsimi, another Canadian innovation to help manage diabetes complications. ...

Read more →

HLS Therapeutics files new drug submission for Perseris in Canada

23 January 2020 - If approved by Health Canada, Perseris would become the first once-monthly risperidone long-acting injectable used in the ...

Read more →

Health Canada approves Keytruda (pembrolizumab) as first-line treatment for patients with advanced renal cell carcinoma

23 January 2020 - Approval based on results of KEYNOTE-426, Where Keytruda in combination with axitinib reduced the risk of death ...

Read more →

Morneau says Ottawa will need to work with provinces on issues like universal pharmacare

19 January 2020 - Finance Minister Bill Morneau said that the federal government will often need to work together with provinces ...

Read more →

Amazon just filed a bunch of international trademarks for ‘Amazon Pharmacy’

21 January 2020 - Amazon bought an Internet pharmacy business called PillPack in 2018. ...

Read more →

Is innovation causing accessibility, timing issues for private drug plans?

17 January 2020 - Pharmaceutical companies and private payers can interact in different ways to ensure the right drugs are ...

Read more →

Why Canada won't end up as the drugstore to the U.S.

16 January 2020 - Although in theory the new U.S. import proposals could significantly affect Canadians and their drug supplies, their ...

Read more →

Cimzia (certolizumab pegol) now approved in Canada for the treatment of non-radiographic axial spondyloarthritis

15 January 2020 - UCB Canada announced today that Health Canada has approved Cimzia (certolizumab pegol) for the treatment of adults ...

Read more →

Health Canada approves Astellas' Xospata (gilteritinib) for patients with relapsed or refractory acute myeloid leukaemia with a FLT3 mutation

14 January 2020 - Xospata is the first and only targeted treatment approved by Health Canada for patients with relapsed or ...

Read more →

B.C. funding decision on pricey drug leaves teen with rare disease facing 'scary' future

13 January 2020 - Miles Ambridge just misses cut-off age to access Spinraza, a potentially life-changing treatment. ...

Read more →

Health insurance industry pooling mechanism makes high cost drugs accessible for record number of Canadians

14 January 2020 - The catastrophic expense of high cost drugs have been made affordable for a record number of ...

Read more →

Alignment of terminology

9 January 2020 - CADTH is aligning the terminology in the single drug review processes as follows: ...

Read more →

New CADTH process for cell and gene therapies

9 January 2020 - CADTH has undertaken an internal review of our processes for drugs and devices, and established a revised ...

Read more →

U.S. health care system costs four times more to run than Canada’s single payer system

7 January 2020 - In the United States, a legion of administrative health care workers and health insurance employees who ...

Read more →

New treatment approved in Canada for most common type of leukaemia

8 January 2020 - Calquence (acalabrutinib) is now available for adult patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. ...

Read more →